Raymond Nims has, since 2009, served as a viral safety consultant to the biopharmaceutical industry, first with RMC Pharmaceutical Solutions, Inc. and since 2023 with Syner-G Biopharma. From 2006 to 2009, Ray was a subject matter expert at Amgen, directing outsourced viral and mycoplasma testing of raw materials and products, and was a business process owner for Amgen’s global contract analytical testing lab outsourcing program. From 1994 to 2006, Ray was employed by BioReliance, directing viral safety, endotoxin, and cell line identity studies for biologics cell line characterization, raw material testing, and product lot release testing.